LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.56234
 27.49 27.76 948 1723 0.5502 0.8091
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 27.49 27.76 974 1723 0.5653 0.8173
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 27.49 27.76 36 1723 0.0209 0.0446
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 27.49 27.76 917 1723 0.5322 0.7990
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 29.19 27.76 949 1863 0.5094 0.7896
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 29.19 27.76 957 1863 0.5137 0.7921
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 29.19 27.76 27 1863 0.0145 -0.0046
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 29.19 27.76 1016 1863 0.5453 0.8098
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 30.90 27.76 1011 2032 0.4975 0.7868
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 30.90 27.76 1025 2032 0.5043 0.7908
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 30.90 27.76 37 2032 0.0182 0.0475
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 30.90 27.76 984 2032 0.4842 0.7790
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 32.60 27.76 965 2235 0.4316 0.7515
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 32.60 27.76 972 2235 0.4347 0.7535
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 32.60 27.76 39 2235 0.0174 0.0552
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 32.60 27.76 1010 2235 0.4517 0.7641
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 34.30 27.76 1012 2449 0.4131 0.7443
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 34.30 27.76 1017 2449 0.4151 0.7457
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 34.30 27.76 47 2449 0.0192 0.0849
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 34.30 27.76 987 2449 0.4029 0.7376
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 36.01 27.76 1144 2662 0.4296 0.7591
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 36.01 27.76 1164 2662 0.4371 0.7638
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
 36.01 27.76 65 2662 0.0244 0.1380
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 36.01 27.76 1010 2662 0.3793 0.7262
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
 37.71 27.76 1096 2877 0.3809 0.7315
MN20160318_Q01
L11